Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Inclusion Criteria

• •COPD diagnosis as defined by the study physician
• •Currently on one of the following maintenance therapies:
• •* LAMA monotherapy
• •* LABA monotherapy
• •* ICS/LABA (FDC)
• •Physician determination that patient is not controlled on current pharmacotherapy
• •Adult patient 40 years of age or older at time of study enrollment
• •Willingness and ability to understand and provide documented Informed Consent Form (ICF) and Health Insurance Portability and Accountability Act (HIPAA) Authorization Form prior to commencement of any study required assessments, either directly or through Legally Authorized Representative.